Michele Boiani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Michele Boiani has a total of 387 co-authors. Here are the top co-authors by number of shared publications:
Steffen Israel
Department of Dermatology, University Hospital Münster, Münster, Germany
16 shared publications- Hans Robert Schöler
Department of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Röntgenstrasse 20, 48149 Münster, Germany
15 shared publications - Sebastian Thomas Balbach
Max-Planck Institute for Molecular Biomedicine, Münster, Germany
13 shared publications Georg Fuellen
Rostock University Medical Center, Institute for Biostatistics and Informatics
12 shared publications- Georg Fuellen
Institute for Biostatistics and Informatics in Medicine and Aging Research (IBIMA), Rostock University Medical Center, Rostock, Germany
11 shared publications - Martin Johannes Pfeiffer
Max Planck Institute for Molecular Biomedicine, Münster, Germany
8 shared publications
Latest Publications
- Open Access
Fertilization offsets the maternal age effect on mouse oocytes provided the oviduct is not itself aged
Advanced maternal age compromises oocyte quality, and it is widely assumed that these deficits are transmitted to embryos. However, because most studies rely on in vivo conception, it has been difficult to separate the effects of oocyte aging from those of an aged fertilization environment. In aging mice, we observed that the fraction of ovulated oocytes forming implantation sites after in vivo conception fell ∼3.7-fold, raising the question of whether this was due to reduced fertilization, reduced embryo quality or reduced support from the aged reproductive tract. Therefore we fertilized oocytes of aged and young mice in vitro with a shared young-donor sperm preparation, holding the fertilization environment constant and removing paternal variability. Hallmarks of maternal age were largely offset following fertilization in vitro : aged oocytes produced blastocysts at rates comparable to young controls, with altered - but not deficient - cell-lineage composition and no detectable impairment in development to term (E18.5) after transfer to young oviducts. Proteomic analysis revealed that, unlike the transcriptomic signature, the oocyte’s proteomic age signature was not faithfully propagated to the blastocyst: for a subset of proteins, particularly those depleted in aged oocytes, the direction of the age effect reversed between oocyte and blastocyst. Comparison with parthenogenetically activated oocytes showed this divergence to be fertilization-dependent, implicating fertilization - rather than mere embryonic cleavage - as the driver of proteomic change. Stable-isotope labelling in live embryos showed that blastocysts from aged, fertilized oocytes both synthesized more new protein and retained less maternal protein than young counterparts; neither effect was detectable after parthenogenesis. Puromycin labelling, by contrast, showed a maternal-age-associated rise in bulk synthesis regardless of route. Together, these results indicate that the maternal-age effect on the oocyte proteome is labile rather than fixed and can be offset by fertilization itself, provided the maternal environment is not itself aged.
Open AccessFertilization offsets the maternal age effect on mouse oocytes provided the oviduct is not itself aged
Advanced maternal age compromises oocyte quality, and it is widely assumed that these deficits are transmitted to embryos. However, because most studies rely on in vivo conception, it has been difficult to separate the effects of oocyte aging from those of an aged fertilization environment. In aging mice, we observed that the fraction of ovulated oocytes forming implantation sites after in vivo conception fell ∼3.7-fold, raising the question of whether this was due to reduced fertilization, reduced embryo quality or reduced support from the aged reproductive tract. Therefore we fertilized oocytes of aged and young mice in vitro with a shared young-donor sperm preparation, holding the fertilization environment constant and removing paternal variability. Hallmarks of maternal age were largely offset following fertilization in vitro : aged oocytes produced blastocysts at rates comparable to young controls, with altered - but not deficient - cell-lineage composition and no detectable impairment in development to term (E18.5) after transfer to young oviducts. Proteomic analysis revealed that, unlike the transcriptomic signature, the oocyte’s proteomic age signature was not faithfully propagated to the blastocyst: for a subset of proteins, particularly those depleted in aged oocytes, the direction of the age effect reversed between oocyte and blastocyst. Comparison with parthenogenetically activated oocytes showed this divergence to be fertilization-dependent, implicating fertilization - rather than mere embryonic cleavage - as the driver of proteomic change. Stable-isotope labelling in live embryos showed that blastocysts from aged, fertilized oocytes both synthesized more new protein and retained less maternal protein than young counterparts; neither effect was detectable after parthenogenesis. Puromycin labelling, by contrast, showed a maternal-age-associated rise in bulk synthesis regardless of route. Together, these results indicate that the maternal-age effect on the oocyte proteome is labile rather than fixed and can be offset by fertilization itself, provided the maternal environment is not itself aged.
- Open Access
- 22 October 2026
- Published by Springer Nature in BMC Genomics
- Vol. 27 (1) , 885
Proteomic and transcriptomic analysis reveals an intracellular role for zona pellucida protein 2 in mouse morula-blastocyst transition
Background: Since the first description in 1827, the zona pellucida (ZP) has been viewed as an extracellular structure surrounding mammalian oocytes, with three canonical roles: encasement of the oocyte in the follicle, sperm binding at fertilization, and physical protection of the early embryo. However, over the past 10 years, mass spectrometry analyses in this laboratory have repeatedly and consistently detected abundant ZP proteins inside mouse embryos. Therefore, this study investigated whether ZP2, the most abundant of the ZP proteins, might also serve non-canonical functions that operate from inside the embryo rather than from the outside. Results: Using mass spectrometry and monoclonal immunofluorescence, an intracellular fraction of ZP2 was found to persist throughout preimplantation mouse development, being among the most abundant proteins of the embryo. Intracellular ZP2 underwent an apparent increase at the 8-cell to morula stage rather than the monotonic decline expected of a passive maternal legacy. Basic colocalization analysis showed that part of this intracellular pool overlapped neither the cis-Golgi marker GM130 nor the endoplasmic reticulum marker Calreticulin, identifying a non-Golgi, non-ER intracellular ZP2 fraction. Consistent with this, ZP2 was susceptible to Trim-Away mediated depletion, which typically can act on a protein only if this is cytosolically accessible. Although ZP2 depletion stalled at approximately 50% due to the enormous abundance of ZP2, this partial knockdown delayed the morula-to-blastocyst transition and produced blastocysts with reduced trophectoderm and primitive endoderm and impaired postimplantation development in vitro and in vivo. These effects were specific to ZP2, as they did not occur when Trim-Away was redirected to an irrelevant target. Proteome and transcriptome analyses of ZP2 knockdown embryos returned overrepresented gene ontology terms related to cytoplasmic translation in the proteome, which was confirmed by an O-propargyl-puromycin incorporation assay; and to endoderm development and gastrulation in the transcriptome, which provide a coherent molecular correlate of the morula retardation phenotype. Conclusions: These results confer ZP2 with hitherto unsuspected intracellular roles during embryogenesis in the mouse model of human reproduction. ZP2 can therefore no longer be referred to as a solely extracellular-operating, oocyte-specific gene product.
- 22 October 2026
- Published by Springer Nature in BMC Genomics
- Vol. 27 (1) , 885
Open AccessProteomic and transcriptomic analysis reveals an intracellular role for zona pellucida protein 2 in mouse morula-blastocyst transition
Background: Since the first description in 1827, the zona pellucida (ZP) has been viewed as an extracellular structure surrounding mammalian oocytes, with three canonical roles: encasement of the oocyte in the follicle, sperm binding at fertilization, and physical protection of the early embryo. However, over the past 10 years, mass spectrometry analyses in this laboratory have repeatedly and consistently detected abundant ZP proteins inside mouse embryos. Therefore, this study investigated whether ZP2, the most abundant of the ZP proteins, might also serve non-canonical functions that operate from inside the embryo rather than from the outside. Results: Using mass spectrometry and monoclonal immunofluorescence, an intracellular fraction of ZP2 was found to persist throughout preimplantation mouse development, being among the most abundant proteins of the embryo. Intracellular ZP2 underwent an apparent increase at the 8-cell to morula stage rather than the monotonic decline expected of a passive maternal legacy. Basic colocalization analysis showed that part of this intracellular pool overlapped neither the cis-Golgi marker GM130 nor the endoplasmic reticulum marker Calreticulin, identifying a non-Golgi, non-ER intracellular ZP2 fraction. Consistent with this, ZP2 was susceptible to Trim-Away mediated depletion, which typically can act on a protein only if this is cytosolically accessible. Although ZP2 depletion stalled at approximately 50% due to the enormous abundance of ZP2, this partial knockdown delayed the morula-to-blastocyst transition and produced blastocysts with reduced trophectoderm and primitive endoderm and impaired postimplantation development in vitro and in vivo. These effects were specific to ZP2, as they did not occur when Trim-Away was redirected to an irrelevant target. Proteome and transcriptome analyses of ZP2 knockdown embryos returned overrepresented gene ontology terms related to cytoplasmic translation in the proteome, which was confirmed by an O-propargyl-puromycin incorporation assay; and to endoderm development and gastrulation in the transcriptome, which provide a coherent molecular correlate of the morula retardation phenotype. Conclusions: These results confer ZP2 with hitherto unsuspected intracellular roles during embryogenesis in the mouse model of human reproduction. ZP2 can therefore no longer be referred to as a solely extracellular-operating, oocyte-specific gene product.
- 2 September 2026
- Published by Springer Nature
- p. 399-423
Targeted Degradation of Mouse Embryo Proteins Using Trim-Away
- 2 September 2026
- Published by Springer Nature
- p. 399-423
Targeted Degradation of Mouse Embryo Proteins Using Trim-Away
- 15 July 2026
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 41 (9) , 1622-1623
Stem cell-based embryo models: scientific promise clashes with ethical reality
- 15 July 2026
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 41 (9) , 1622-1623
Stem cell-based embryo models: scientific promise clashes with ethical reality
- 7 January 2026
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 32 (1)
Call for papers—shaping reproduction in 3D: organoids, assembloids, and emerging models
- 7 January 2026
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 32 (1)
Call for papers—shaping reproduction in 3D: organoids, assembloids, and emerging models
- Open Access
- 7 January 2026
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 32 (1)
MHR : the first 30 years
Thirty years ago, Robert G. Edwards, the Nobel Prize winner for his pioneering work on IVF, launched Molecular Human Reproduction (MHR) and became its inaugural Editor-in-Chief. Originally starting as a section within Human Reproduction (HR) on 1 March 1995 ( Edwards and Beard, 1995), MHR went on to become a self-contained journal on 1 January 1996 ( Edwards et al., 1996), whose mission was to feature the rapid development of molecular studies. I want to celebrate this momentous anniversary by reviewing MHR’s journey—in chronological order and through each Editor-in-Chief (EiC) term, concluding with my own assessment of where MHR stands now. The latter will include my thoughts of what makes MHR a strong journal that knows how to seize the opportunities of the times, and also a journal that faces challenges—some global, but others related to the nature of MHR itself. We will take this journey both in words and with the support of a graphic timeline ( Fig. 1).
- 7 January 2026
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 32 (1)
Open AccessMHR : the first 30 years
Thirty years ago, Robert G. Edwards, the Nobel Prize winner for his pioneering work on IVF, launched Molecular Human Reproduction (MHR) and became its inaugural Editor-in-Chief. Originally starting as a section within Human Reproduction (HR) on 1 March 1995 ( Edwards and Beard, 1995), MHR went on to become a self-contained journal on 1 January 1996 ( Edwards et al., 1996), whose mission was to feature the rapid development of molecular studies. I want to celebrate this momentous anniversary by reviewing MHR’s journey—in chronological order and through each Editor-in-Chief (EiC) term, concluding with my own assessment of where MHR stands now. The latter will include my thoughts of what makes MHR a strong journal that knows how to seize the opportunities of the times, and also a journal that faces challenges—some global, but others related to the nature of MHR itself. We will take this journey both in words and with the support of a graphic timeline ( Fig. 1).
- Open Access
- 7 January 2026
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 32 (1)
Variable partition of non-homogeneous ooplasm sets the stage for divergent potency of 2-cell stage blastomeres
Following fertilization in mice and humans, the first two blastomeres are not equivalent, but one produces more epiblast than the other (imbalance); therefore, they do not feature equal totipotency. Research into the causes has overlooked that the epiblast imbalance is preceded by a fertilization imbalance, since in nature, the spermatozoon fertilizes the oocyte preferentially in the animal hemisphere near the animal–vegetal midline (equator). We conceived a hypothesis that the two imbalances are linked to each other, and broke it down into testable predictions. If the two imbalances were interdependent, then changing the site of sperm entry into the oocyte should change the extent of the epiblast imbalance. Thus, we evened out the fertilization imbalance, using ICSI to fertilize mouse oocytes also in the vegetal hemisphere and the equator. Resultant embryos were split at the 2-cell stage, and the twin blastocysts originating from the sister blastomeres were analyzed. Against the similarity in mRNA levels of epiblast genes, twin blastocysts differed in epiblast function, as measured by NANOG protein expression and derivation of embryonic stem cells, and the epiblast imbalance was greater after oocyte fertilization at the equator. There is no simple way to explain the positional effect other than through differences in the molecular composition of the ooplasm, which, moreover, should also be apportioned variably at the first zygotic division. We tested these predictions by measuring the orientation of the first zygotic division regarding the ICSI site, and the composition of bisected oocytes’ hemispheres using half-cell proteomics. Since we found that the hemispheres have different compositions depending on the bisection axis, and the angle of the first division is variable, we propose that the variable partition of non-homogeneous ooplasm sets the stage for the epiblast imbalance. These results revive the role of the oocyte’s molecular architecture on embryogenesis in a mammalian species hitherto considered mostly regulative in development.
- 7 January 2026
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 32 (1)
Open AccessVariable partition of non-homogeneous ooplasm sets the stage for divergent potency of 2-cell stage blastomeres
Following fertilization in mice and humans, the first two blastomeres are not equivalent, but one produces more epiblast than the other (imbalance); therefore, they do not feature equal totipotency. Research into the causes has overlooked that the epiblast imbalance is preceded by a fertilization imbalance, since in nature, the spermatozoon fertilizes the oocyte preferentially in the animal hemisphere near the animal–vegetal midline (equator). We conceived a hypothesis that the two imbalances are linked to each other, and broke it down into testable predictions. If the two imbalances were interdependent, then changing the site of sperm entry into the oocyte should change the extent of the epiblast imbalance. Thus, we evened out the fertilization imbalance, using ICSI to fertilize mouse oocytes also in the vegetal hemisphere and the equator. Resultant embryos were split at the 2-cell stage, and the twin blastocysts originating from the sister blastomeres were analyzed. Against the similarity in mRNA levels of epiblast genes, twin blastocysts differed in epiblast function, as measured by NANOG protein expression and derivation of embryonic stem cells, and the epiblast imbalance was greater after oocyte fertilization at the equator. There is no simple way to explain the positional effect other than through differences in the molecular composition of the ooplasm, which, moreover, should also be apportioned variably at the first zygotic division. We tested these predictions by measuring the orientation of the first zygotic division regarding the ICSI site, and the composition of bisected oocytes’ hemispheres using half-cell proteomics. Since we found that the hemispheres have different compositions depending on the bisection axis, and the angle of the first division is variable, we propose that the variable partition of non-homogeneous ooplasm sets the stage for the epiblast imbalance. These results revive the role of the oocyte’s molecular architecture on embryogenesis in a mammalian species hitherto considered mostly regulative in development.
- Open Access
A novel and critical role of the intracellular Zona Pellucida protein 2 (ZP2) for blastocyst formation in mice
The zona pellucida (ZP) is the quintessential extracellular structure of mammalian oocytes. Contrary to long-standing view that the synthesis of ZP proteins is specific to oocytes and muted in embryos, we report here that the major zona pellucida protein ZP2 is re-synthesized and functionally required during mouse embryo development. The orthogonal methods of mass spectrometry and monoclonal immunofluorescence revealed an increase of ZP2 abundance at the 8-cell / morula stage, which did not occur when zygotes were microinjected with translation-blocking oligonucleotides (morpholinos). To shed light on the functional significance of embryonic ZP2, we performed protein knockdown using immunodepletion (by Trim-Away) while at the same time preventing replenishment (by translation-blocking morpholino). ZP2 knockdown resulted in morula stage retardation and formation of defective blastocysts, whose cell lineages trophectoderm and primitive endoderm were smaller and less able to support post-implantation development. The transcriptional correlates of these morphological alterations had a gene ontology (biological process) signature that included cell lineage-relevant terms (endoderm development, gastrulation), while the proteomic correlates had a gene ontology signature related to protein synthesis. Taken together, these results call into question the traditional model that ZP proteins function solely in the extracellular space and accompany embryogenesis as passive bystanders: on the contrary, ZP proteins also participate actively in the intracellular processes of early embryogenesis.
Open AccessA novel and critical role of the intracellular Zona Pellucida protein 2 (ZP2) for blastocyst formation in mice
The zona pellucida (ZP) is the quintessential extracellular structure of mammalian oocytes. Contrary to long-standing view that the synthesis of ZP proteins is specific to oocytes and muted in embryos, we report here that the major zona pellucida protein ZP2 is re-synthesized and functionally required during mouse embryo development. The orthogonal methods of mass spectrometry and monoclonal immunofluorescence revealed an increase of ZP2 abundance at the 8-cell / morula stage, which did not occur when zygotes were microinjected with translation-blocking oligonucleotides (morpholinos). To shed light on the functional significance of embryonic ZP2, we performed protein knockdown using immunodepletion (by Trim-Away) while at the same time preventing replenishment (by translation-blocking morpholino). ZP2 knockdown resulted in morula stage retardation and formation of defective blastocysts, whose cell lineages trophectoderm and primitive endoderm were smaller and less able to support post-implantation development. The transcriptional correlates of these morphological alterations had a gene ontology (biological process) signature that included cell lineage-relevant terms (endoderm development, gastrulation), while the proteomic correlates had a gene ontology signature related to protein synthesis. Taken together, these results call into question the traditional model that ZP proteins function solely in the extracellular space and accompany embryogenesis as passive bystanders: on the contrary, ZP proteins also participate actively in the intracellular processes of early embryogenesis.
- Open Access
Maternal CENP-C restores centromere symmetry in mammalian zygotes to ensure proper chromosome segregation
Summary: Across metazoan species, the centromere-specific histone variant CENP-A is essential for accurate chromosome segregation, yet its regulation at the parental-to-zygote transition in mammals is poorly understood. To address this, we developed a CENP-A-mScarlet knock-in mouse model, which revealed sex-specific dynamics: mature sperm retains 10% of the CENP-A levels present in MII-oocytes. However, in zygotes prior to the first mitosis, this difference is resolved, using maternally inherited cytoplasmic-CENP-A. Notably, the increase in CENP-A at paternal centromeres is independent of sensing CENP-A asymmetry or the presence of maternal chromosomes. Instead, CENP-A equalization relies on asymmetric recruitment of maternal CENP-C to paternal centromeres. Depletion of maternal CENP-A decreases total CENP-A in pronuclei without disrupting equalization. In contrast, reducing maternal CENP-C or disruption of its dimerization domains impairs CENP-A equalization and chromosome segregation. Therefore, maternal CENP-C acts a key epigenetic regulator that resets centromeric symmetry at fertilization to preserve genome integrity. Highlights: ● CENP-A asymmetry between sperm and oocyte centromeres is a conserved feature from flies to mammals including mice and humans. ● CENP-A asymmetry between parental centromeres is resolved prior to the first zygotic division via maternally inherited, cytoplasmic CENP-A. ● Zygotic CENP-A levels in zygotes are regulated in a pronucleus-autonomous manner. ● CENP-A equalization relies on asymmetric CENP-C recruitment to the paternal pronucleus and requires CENP-C dimerization. Key Terms: Centromere; CENP-A; CENP-C; sperm; oocyte; zygote; intergenerational; epigenetics; mouse
Open AccessMaternal CENP-C restores centromere symmetry in mammalian zygotes to ensure proper chromosome segregation
Summary: Across metazoan species, the centromere-specific histone variant CENP-A is essential for accurate chromosome segregation, yet its regulation at the parental-to-zygote transition in mammals is poorly understood. To address this, we developed a CENP-A-mScarlet knock-in mouse model, which revealed sex-specific dynamics: mature sperm retains 10% of the CENP-A levels present in MII-oocytes. However, in zygotes prior to the first mitosis, this difference is resolved, using maternally inherited cytoplasmic-CENP-A. Notably, the increase in CENP-A at paternal centromeres is independent of sensing CENP-A asymmetry or the presence of maternal chromosomes. Instead, CENP-A equalization relies on asymmetric recruitment of maternal CENP-C to paternal centromeres. Depletion of maternal CENP-A decreases total CENP-A in pronuclei without disrupting equalization. In contrast, reducing maternal CENP-C or disruption of its dimerization domains impairs CENP-A equalization and chromosome segregation. Therefore, maternal CENP-C acts a key epigenetic regulator that resets centromeric symmetry at fertilization to preserve genome integrity. Highlights: ● CENP-A asymmetry between sperm and oocyte centromeres is a conserved feature from flies to mammals including mice and humans. ● CENP-A asymmetry between parental centromeres is resolved prior to the first zygotic division via maternally inherited, cytoplasmic CENP-A. ● Zygotic CENP-A levels in zygotes are regulated in a pronucleus-autonomous manner. ● CENP-A equalization relies on asymmetric CENP-C recruitment to the paternal pronucleus and requires CENP-C dimerization. Key Terms: Centromere; CENP-A; CENP-C; sperm; oocyte; zygote; intergenerational; epigenetics; mouse
- 3 July 2025
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 31 (3)
‘Small but mighty’: the Concise Communication comes to MHR
- 3 July 2025
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 31 (3)
‘Small but mighty’: the Concise Communication comes to MHR